August 19, 2016
altona Diagnostics (Hamburg, Germany) reports that its Zika Virus RT-PCR Kit 1.0 has been listed by WHO as first in vitro diagnostic test eligible for procurement agencies and member states. The kit was assessed under the Emergency Use Assessment and Listing Procedure (EUAL), an emergency assessment mechanism established by WHO during the 2014 Ebola Virus Disease outbreak. A public report with additional details about the WHO EUAL listing for the testing kit for can be found at http://www.who.int/diagnostics_laboratory/eual-zika-virus/zika/en/
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.